BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 21278237)

  • 21. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.
    Pourgholami MH; Cai ZY; Badar S; Wangoo K; Poruchynsky MS; Morris DL
    BMC Cancer; 2010 Apr; 10():143. PubMed ID: 20398289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer.
    Liu Y; Han ZP; Zhang SS; Jing YY; Bu XX; Wang CY; Sun K; Jiang GC; Zhao X; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    J Biol Chem; 2011 Jul; 286(28):25007-15. PubMed ID: 21592963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute hypoxia exposure with different durations on activation of Nrf2-ARE pathway in mouse skeletal muscle.
    Ji W; Wang L; He S; Yan L; Li T; Wang J; Kong AT; Yu S; Zhang Y
    PLoS One; 2018; 13(12):e0208474. PubMed ID: 30513114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.
    Mahajan M; Sitasawad S
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
    Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
    Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression.
    Fang J; Zhou Q; Liu LZ; Xia C; Hu X; Shi X; Jiang BH
    Carcinogenesis; 2007 Apr; 28(4):858-64. PubMed ID: 17071632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia.
    Park SY; Jang WJ; Yi EY; Jang JY; Jung Y; Jeong JW; Kim YJ
    J Pineal Res; 2010 Mar; 48(2):178-84. PubMed ID: 20449875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of hypoxia-inducible factor 1alpha in gastric cancer cell growth, angiogenesis, and vessel maturation.
    Stoeltzing O; McCarty MF; Wey JS; Fan F; Liu W; Belcheva A; Bucana CD; Semenza GL; Ellis LM
    J Natl Cancer Inst; 2004 Jun; 96(12):946-56. PubMed ID: 15199114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential transcriptional regulation of hypoxia-inducible factor-1α by arsenite under normoxia and hypoxia: involvement of Nrf2.
    Al Taleb Z; Petry A; Chi TF; Mennerich D; Görlach A; Dimova EY; Kietzmann T
    J Mol Med (Berl); 2016 Oct; 94(10):1153-1166. PubMed ID: 27286880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
    Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway.
    Zheng Y; Chen H; Zhao Y; Zhang X; Liu J; Pan Y; Bai J; Zhang H
    Invest New Drugs; 2020 Feb; 38(1):20-28. PubMed ID: 30887251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1alpha promotes nonhypoxia-mediated proliferation in colon cancer cells and xenografts.
    Dang DT; Chen F; Gardner LB; Cummins JM; Rago C; Bunz F; Kantsevoy SV; Dang LH
    Cancer Res; 2006 Feb; 66(3):1684-936. PubMed ID: 16452228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
    Roda JM; Sumner LA; Evans R; Phillips GS; Marsh CB; Eubank TD
    J Immunol; 2011 Aug; 187(4):1970-6. PubMed ID: 21765015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nrf2 Activation Induced by Sirt1 Ameliorates Acute Lung Injury After Intestinal Ischemia/Reperfusion Through NOX4-Mediated Gene Regulation.
    Chai D; Zhang L; Xi S; Cheng Y; Jiang H; Hu R
    Cell Physiol Biochem; 2018; 46(2):781-792. PubMed ID: 29621765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.